30,269 results on '"DIPHTHERIA"'
Search Results
2. Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy
3. Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
4. Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
5. Cutaneous Diphtheria in France : Observational, Retrospective Study of Patient Characteristics (OEDIPE)
6. A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
7. A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
8. Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors
9. Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
10. Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. (Clodivac)
11. Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML (GO-TAG)
12. Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
13. The immune status of migrant populations in Europe and implications for vaccine-preventable disease control: a systematic review and meta-analysis.
14. Retrospective Study of Infections with Corynebacterium diphtheriae Species Complex, French Guiana, 2016–2021
15. Contagious Diseases
16. A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
17. Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
18. Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy (ITAPP)
19. Post Marketing Surveillance of Diphtheria Antitoxin (DAT)
20. Challenges of Diphtheria Toxin Detection.
21. Neutralizing anti-diphtheria toxin scFv produced by phage display.
22. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges.
23. Cluster of Nontoxigenic Corynebacterium diphtheriae Infective Endocarditis and Rising Background C. diphtheriae Cases—Seattle, Washington, 2020–2023.
24. Diphtheria in a Swiss Asylum Seeker Reception Centre: Outbreak Investigation and Evaluation of Testing and Vaccination Strategies.
25. Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints.
26. 'The existing state of affairs is a disgrace and a positive danger to the town': Water-borne disease and sanitation in the Beaufort West Municipality, 1848-1955.
27. Identification and antibiogram of clinically relevant nondiphtheriae Corynebacterium species.
28. Evidence for Immunity against Tetanus, Diphtheria, and Pertussis through Natural Infection or Vaccination in Adult Solid Organ Transplant Recipients: A Systematic Review.
29. Diphtheria and Tetanus Immunity Status among Greek Adults: Results from a Nationwide Seroprevalence Study.
30. Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China.
31. A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults
32. Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa
33. 45-year-old Male with Bilateral Lower Extremity Wounds, Swelling, and Rash
34. Management and outcome of cutaneous diphtheria in adolescent refugees in Germany, June 2022 – October 2023
35. Clinical spectrum and outcomes of the 2019-2020 pediatric diphtheria outbreak in Yemen
36. Infections, Including Endocarditis, Due to Non-Toxigenic Corynebacterium diphtheriae.
37. Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS (Venus)
38. A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)
39. Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines
40. WHO publishes first-ever guidance on the Clinical Management of Diphtheria.
41. WHO publishes first-ever guidance on the Clinical Management of Diphtheria.
42. Antimicrobial resistance patterns and empiric antibiotic selections for patients admitted from post–acute care facilities.
43. Zoonotic transmission of diphtheria toxin‐producing Corynebacterium ulcerans.
44. Pastern dermatitis outbreak associated with toxigenic and non‐toxigenic Corynebacterium diphtheriae and non‐toxigenic Corynebacterium ulcerans at a horse stable in Finland, 2021.
45. Assessing the impact of booster vaccination on diphtheria transmission: Mathematical modeling and risk zone mapping.
46. A CROSS SECTIONAL STUDY ON CLINICAL AND LABORATORY PROFILE OF DIPHTHERITIC PATIENTS ADMITTED IN INFECTIOUS DISEASE HOSPITAL, HYDERABAD, TELANGANA.
47. Epidemiological and Clinical Characteristics of Patients with Diphtheria Attending the Infectious Disease Hospital in Delhi.
48. Diphtheria Toxoid Particles as Q Fever Vaccine.
49. Unmasking diphtheria in Nigeria: A multifaceted approach to tackle outbreaks and improve immunization rates among the Nigerian population—An updated correspondence.
50. Access to DTP-Based Combination Vaccines in Asia–Pacific Countries between 2019 and 2022.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.